Yüklüyor......
Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer
BACKGROUND: Delays in the initiation of therapy among patients with early stage breast cancer (BC) can negatively affect outcomes. Patients treated with neoadjuvant systemic chemotherapy (NSC) usually display tumors with high‐risk features. Considering these high‐risk characteristics and the evidenc...
Kaydedildi:
| Yayımlandı: | Oncologist |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485349/ https://ncbi.nlm.nih.gov/pubmed/32431013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0744 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|